Direct costs associated with the disease management of patients with unresectable advanced non-small-cell lung cancer in The NetherlandsPOMPEN, Marjolein; GOK, Murat; NOVAK, Annoesjka et al.Lung cancer. 2009, Vol 64, Num 1, pp 110-116, issn 0169-5002, 7 p.Article

Randomized Phase II Study of Gefitinib Compared With Placebo in Chemotherapy-Naive Patients With Advanced Non-Small-Cell Lung Cancer and Poor Performance StatusGOSS, Glenwood; FERRY, David; ZARENDA, Marc et al.Journal of clinical oncology. 2009, Vol 27, Num 13, pp 2253-2260, issn 0732-183X, 8 p.Article

Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancerVAN MEERBEECK, Jan P; KRAMER, Gijs W. P. M; SPLINTER, Ted A. W et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 6, pp 442-450, issn 0027-8874, 9 p.Article

Phase III study of cyclophosphamide, doxorubicin, and etoposide compared with carboplatin and paclitaxel in patients with extensive disease small-cell lung cancerDE JONG, Wouter K; GROEN, Harry J. M; KOOLEN, Mia G. J et al.European journal of cancer (1990). 2007, Vol 43, Num 16, pp 2345-2350, issn 0959-8049, 6 p.Article

Quality assurance of thoracic radiotherapy in EORTC 08941 : A randomised trial of surgery versus thoracic radiotherapy in patients with stage IIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapyKRAMER, Gijsbert W. P. M; LEGRAND, Catherine L; GIACCONE, Giuseppe et al.European journal of cancer (1990). 2006, Vol 42, Num 10, pp 1391-1398, issn 0959-8049, 8 p.Article

Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Gemcitabine/Cisplatin Alone or With Sorafenib for the First-Line Treatment of Advanced, Nonsquamous Non―Small-Cell Lung CancerPAZ-ARES, Luis G; BIESMA, Bonne; SYRIGOS, Kostas et al.Journal of clinical oncology. 2012, Vol 30, Num 25, pp 3084-3092, issn 0732-183X, 9 p.Article

A randomized phase II study of bortezomib and pemetrexed, in combination or alone, in patients with previously treated advanced non-small-cell lung cancerSCAGLIOTTI, Giorgio V; GERMONPRE, Paul; BIESMA, Bonne et al.Lung cancer. 2010, Vol 68, Num 3, pp 420-426, issn 0169-5002, 7 p.Article

Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer : A dutch randomized phase iii studyTIMMER-BONTE, Johanna N; DE BOO, Theo M; BOOTSMA, Geeben P et al.Journal of clinical oncology. 2005, Vol 23, Num 31, pp 7974-7984, issn 0732-183X, 11 p.Article

Prognostic relevance of response evaluation using [¹⁸F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancerHOEKSTRA, Corneline J; STROOBANTS, Sigrid G; LAMMERTSMA, Adriaan A et al.Journal of clinical oncology. 2005, Vol 23, Num 33, pp 8362-8370, issn 0732-183X, 9 p.Article

Phase II study of pemetrexed and cisplatin plus cetuximab followed by pemetrexed and cetuximab maintenance therapy in patients with advanced nonsquamous non-small cell lung cancerSCHMID-BINDERT, Gerald; GEBBIA, Vittorio; MYRAND, Scott P et al.Lung cancer. 2013, Vol 81, Num 3, pp 428-434, issn 0169-5002, 7 p.Article

Randomized, Placebo-Controlled Phase III Study of Docetaxel Plus Carboplatin With Celecoxib and Cyclooxygenase-2 Expression As a Biomarker for Patients With Advanced Non―Small-Cell Lung Cancer: The NVALT-4 StudyGROEN, Harry J. M; SIETSMA, Hannie; HILTERMANN, T. Jeroen N et al.Journal of clinical oncology. 2011, Vol 29, Num 32, pp 4320-4326, issn 0732-183X, 7 p.Article

Phase III Trial Comparing Vinflunine With Docetaxel in Second-Line Advanced Non-Small-Cell Lung Cancer Previously Treated With Platinum-Containing ChemotherapyKRZAKOWSKI, Maciej; RAMLAU, Rodryg; DELGADO, François M et al.Journal of clinical oncology. 2010, Vol 28, Num 13, pp 2167-2173, issn 0732-183X, 7 p.Article

Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non-Small-Cell Lung CancerSMIT, Egbert F; BURGERS, Sjaak A; GROEN, Harry J. M et al.Journal of clinical oncology. 2009, Vol 27, Num 12, pp 2038-2045, issn 0732-183X, 8 p.Article

Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus Gemcitabine in advanced non-small-cell lung cancer: A phase III trial of the european organization for research and treatment of cancer lung cancer group: EORTC 08975SMIT, Egbert F; VAN MEERBEECK, Jan P. A. M; NEYMARK, Niels et al.Journal of clinical oncology. 2003, Vol 21, Num 21, pp 3909-3917, issn 0732-183X, 9 p.Article